COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,002 | +4.0% | 2,103 | 0.0% | 0.00% | – |
| Q2 2023 | $45,193 | +90286.0% | 2,103 | 0.0% | 0.00% | – |
| Q1 2023 | $50 | -10.7% | 2,103 | -13.2% | 0.00% | – |
| Q4 2022 | $56 | -99.9% | 2,423 | 0.0% | 0.00% | – |
| Q3 2022 | $43,000 | +2.4% | 2,423 | +1.4% | 0.00% | – |
| Q2 2022 | $42,000 | +366.7% | 2,390 | +443.2% | 0.00% | – |
| Q1 2022 | $9,000 | -89.5% | 440 | -90.8% | 0.00% | -100.0% |
| Q4 2021 | $86,000 | -45.2% | 4,799 | -39.7% | 0.00% | 0.0% |
| Q3 2021 | $157,000 | +946.7% | 7,955 | +1183.1% | 0.00% | – |
| Q2 2021 | $15,000 | 0.0% | 620 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | +25.0% | 620 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | -81.5% | 620 | -80.1% | 0.00% | -100.0% |
| Q3 2020 | $65,000 | +400.0% | 3,112 | +332.2% | 0.00% | – |
| Q2 2020 | $13,000 | -7.1% | 720 | -16.8% | 0.00% | – |
| Q1 2020 | $14,000 | -22.2% | 865 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | -81.6% | 865 | -89.8% | 0.00% | -100.0% |
| Q3 2019 | $98,000 | – | 8,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |